Admedus Ltd. engages in the development, commercialization, and distribution of medical products and technologies. It operates through the following segments: Disposable Medical Products and Medical Services Distribution, Bio Implant Operations, Regenerative Medicine Research and Development (R&D), Immunotherapies R&D. The comapny also offers tissue engineering, CardioCel, and other medical products. Admedus was founded June 2011 and is headquartered in Perth, Australia.
Integrated Research (ITI) and Objective Corporation (OCL) lost their A1 Skaffold Scores overnight. Macquarie Telecom (MAQ), Resource Equipment (RQL) and Coventry Group (CYG) fell from A2 to A3, and Blue Sky Alternative Investments (BLA) and Pro Medicus (PME) from A2 to A4. Yesterday 87 companies achieved Skaffold’s A2 Score for quality and performance. Today that number stands at 82.